Investigation of the metabolism of azaperone in the horse.

The research paper explores the metabolism of azaperone, a sedative, in horses with the use of methods such as LC-MS-MS analysis, urine analysis, and XAD-2 resin extraction. The paper successfully identifies several metabolites of azaperone in horse urine, both in their unconjugated and conjugated forms.

Methods Used

• The researchers administered 40mg of azaperone to a horse intramuscularly and collected urine samples for analysis.
• The urine samples were extracted at a pH level of 10, both before and after undergoing acid hydrolysis. Acid hydrolysis is the process of breaking down a compound by exposing it to an acidic condition.
• The extracted samples were concentrated, meaning excess solvent was removed to enhance the samples’ content, and analyzed using Liquid Chromatography – Tandem Mass Spectrometry (LC-MS-MS). This method allows the identification and quantification of chemicals in a sample.
• They also used XAD-2 resin extraction, a method for extracting organic substances from fluids, to identify glucuronide conjugated azaperone metabolites in the urine.

Findings

• Two N-dealkylated metabolites – N-despyridinylazaperol and N-despyridinylazaperone, and a small amount of azaperone were identified in the unhydrolyzed urine.
• The acid-hydrolyzed urine exhibited six metabolites – hydroxyazaperol, two types of hydroxyazaperones, azaperol, N-despyridinylazaperol, and N-despyridinylazaperone.
• Using XAD-2 resin extraction, three glucuronide conjugated metabolites – hydroxyazaperol glucuronide, hydroxyazaperone glucuronide, and azaperol glucuronide, were discovered in the horse urine.
• These glucuronide-conjugated metabolites shared similar characteristic daughter ions as the unconjugated metabolites, as revealed by their mass spectra.
• The researchers also found that the glucuronide-conjugated azaperone metabolites were partially hydrolyzed to their unconjugated forms, as observed via heated nebulizer interface – a method used in sample analysis of volatile compounds through heat and aerosol production.

Implications

• The research sheds light on the metabolic pathways of azaperone in horses. This knowledge is useful in fields such as veterinary science, where understanding drug metabolism is needed for effective management of dosages and potential side-effects.
• The identification of both conjugated and unconjugated metabolites helps in establishing a comprehensive metabolite profile, which might assist in future drug screenings and toxicological studies related to azaperone usage in horses.